Study objectives: Diffuse parenchymal lung disease is associated with a high risk of mortality despite early referral and listing for lung transplantation. We hypothesized that cardiopulmonary exercise test results and the distance walked in 6 min (6MWTD) would be associated with survival in patients with diffuse parenchymal lung disease referred for lung transplantation. Design: Retrospective cohort study. Setting: Tertiary care center. Patients: We included 51 consecutive patients with diffuse parenchymal lung disease who underwent exercise testing after referral to the Lung Transplant Program at the New York Presbyterian Hospital between January 2000 and December 2002. Thirty-three patients were listed, and 7 underwent transplantation during the study period. There were 17 deaths with 1 death post-transplantation. Results: A 6MWTD o350 m was associated with an increased risk of death (HR ¼ 4.6, 95% CI 1.5-14.2, P ¼ 0:009). Oxygen saturation with unloaded exercise (HR ¼ 0.91, 95% CI 0.84-0.98, P ¼ 0:015) and oxygen consumption at peak exercise adjusted for weight (HR ¼ 0.88, P ¼ 0:039) were also associated with the risk of death. A patient with oxygen saturation o95% during unloaded exercise had a 75% chance of dying on the list for transplantation. A patient with 6MWTD o350 m had a 67% chance of dying on the list. Conclusions: Cardiopulmonary exercise test parameters and the 6MWTD were associated with the risk of death. Measures during exercise may be useful for determination of prognosis and for prioritizing patients with diffuse parenchymal lung disease for lung transplantation.
Introduction
Interstitial lung disease has recently been reclassified as ' ' diffuse parenchymal lung disease'' (DPLD). 1 Many forms of DPLD are associated with a poor prognosis and high risk of mortality. Although certain types of DPLD respond to medical therapy, lung transplantation often is the only viable therapeutic option. Unfortunately, patients with DPLD have a higher risk of death on the waiting list compared to that of patients with other diagnoses. 2 Although lung function, histology, and radiographic appearance have been associated with outcomes in patients with usual interstitial pneumonia (UIP), [3] [4] [5] [6] [7] [8] [9] these parameters are not necessarily valid in a broader cohort of patients with DPLD referred for transplantation after failure of medical therapies.
Patients with DPLD often demonstrate an abnormal cardiopulmonary response to exercise. The limitation to exercise in DPLD is multifactorial, incorporating cardiac, ventilatory, vascular, and muscular components. Cardiopulmonary exercise testing (CPET) measures these determinants of exercise performance and may shed light on the physiologic mechanisms of morbidity and mortality in DPLD. Although the 6 min walk test also quantifies exercise performance, this test provides less information regarding specific limiting factors and is therefore considered complementary to CPET. 10 The clinical role of CPET and the 6 min walk test in the assessment of prognosis in patients with DPLD is unclear. [10] [11] [12] [13] [14] We hypothesized that CPET results and the distance walked in 6 min (6MWTD) would be associated with survival in patients with advanced DPLD. We also assessed the ability of CPET and 6MWTD to discriminate listed patients who died before receiving a lung transplant from those who were alive on the list or who received lung transplants.
Methods and materials Study subjects and design
We performed a retrospective cohort study of consecutive patients with DPLD who underwent CPET after referral to the Lung Transplant Program at New York Presbyterian Hospital between January 2000 and December 2002. Patients with a diagnosis of idiopathic interstitial pneumonia or DPLD of known cause using standard criteria 1 and evaluation for lung transplantation with CPET between January 2000 and December 2002 were included. Patients with previous evaluation for lung transplantation at another center or other forms of DPLD (e.g., sarcoid) were excluded. The study was approved by the Western Institutional Review Board.
Methods
We collected data including patient demographics, spirometry, lung volumes, diffusion capacity for carbon monoxide (DLCO), and hemodynamic measurements from right heart catheterization. Pulmonary hypertension was defined by mean pulmonary artery pressure 425 mmHg. Two pulmonologists (S.M.A. and S.M.K.) independently assigned diagnoses according to American Thoracic Society (ATS) guidelines, which incorporate diagnostic criteria with or without lung biopsy. 1 Disagreements were resolved by consensus. Primary outcomes included (1) all-cause mortality and (2) death on the waiting list for transplantation. We assessed outcomes through chart review and search of the Social Security Death Index. A patient was considered to be alive at the last medical contact noted in the chart if it was within 3 months of the completion of the study period (February 15, 2003) . For patients who were not seen in the previous 3 months, the referring physicians were contacted for follow-up.
CPET was performed on a single bicycle ergometer (Ergometrics 800, Sensormedics Inc., Yorba Linda, CA) with a metabolic cart (Sensormedics Vmax 229, Sensormedics Inc., Yorba Linda, CA). Patients receiving supplemental home oxygen therapy or who had room air oxygen saturation o90% (N ¼ 31) were exercised with 30% fractional oxygen via mouthpiece. After 5 min of rest on the ergometer, subjects underwent unloaded pedaling for 3 min. We used an established ramp watt protocol for exercise testing with 5, 10, or 15 W/ min testing. During all subject testing, we monitored continuous 12-Lead telemetry (Marquette Max-1), and oxygen saturation by pulse oximetry (Sensormedics Sat-Trak). Oxygen consumption (VO 2 ) and carbon dioxide production (VCO 2 ) were calculated on a breath-by-breath basis with 20-s averaging. Recovery measurements were recorded at one minute after maximal exercise. The anaerobic threshold (AT) was determined using the VSlope method of analysis. Reference values for CPET were calculated from standard sources. 11, 15 Six minute walk testing was performed (N ¼ 43) with (N ¼ 25) or without (N ¼ 18) supplemental oxygen, as recommended by ATS guidelines. 10 
Analysis
Continuous variables were summarized by the mean7standard deviation or median (range). Categorical variables were summarized by the frequency (95% confidence interval (CI)). Unpaired t-tests, Wilcoxon rank-sum tests, chi-square tests, and Fisher's exact tests were used, as appropriate.
We performed two distinct analyses to address the two different aims of the study. First, we used Cox proportional hazards regression to identify predictors of time-to-death. 16 The hazard ratios derived from these models are similar to the relative risks of death when comparing patients. We constructed individual models with lung transplantation as a time-dependent covariate. This analysis ' ' controls'' for receiving a transplant (or eliminates this as a factor) to understand if there are CPET parameters reflecting cardiac or musculoskeletal limitation which may be associated with survival even if the patient proceeds to lung transplantation. Others have used a similar methodology to study patients with pulmonary fibrosis undergoing lung transplantation. 17, 18 In a second analysis, we attempted to define optimal cutoffs for variables which were associated with dying on the waiting list for transplantation. This methodology is based only on (1) whether a patient died waiting for lungs or (2) was alive at the end of the study or underwent lung transplantation. We assessed continuous variables from the previous analyses with receiver operating characteristic (ROC) curves. Areas (95% CI) under the ROC curves were calculated. Cutpoints which maximized sensitivity and specificity were selected.
In the proportional hazards models, nonlinearity of continuous variables was assessed, and transformations or cutpoints were chosen based on optimal model fit. The proportional hazards assumption was examined for all significant predictors using Schoenfeld residuals and tests based on weighted residuals. 19 Variables which did not meet this assumption were included in the models with interaction terms with time. We evaluated the data for potentially influential observations using delta-beta statistics. P values o0.05 were considered statistically significant. Stata 7.0 (College Station, TX) was used for all analyses.
Results
We identified 51 consecutive patients who met eligibility criteria for this study. Twenty-eight (55%) patients had UIP, and 4 (8%) additional patients had UIP pattern with collagen vascular disease. Other diagnoses included non-specific interstitial pneumonia (6), hypersensitivity pneumonitis (2), desquamative interstitial pneumonia (1), cryptogenic organizing pneumonia (1), lymphoid interstitial pneumonia (1), asbestosis (1), and unclassifiable interstitial pneumonia (7). Thirty-five (69%) patients in the cohort had undergone surgical lung biopsy. Patients with any missing exercise data (N ¼ 10) were not significantly different from patients with complete data in terms of age, gender, race, and survival (all P40:10).
Demographic, pulmonary function and hemodynamic data are summarized in Table 1 . Patients who died were more likely to be black or Hispanic and had lower DLCO and higher pulmonary artery pressures than patients who lived. 6WMTD and CPET measurements at peak exercise are shown in Table 2 . Patients who died had lower 6MWTD, peak work, and peak oxygen saturation than those who were alive. Reasons for stopping exercise during CPET included dyspnea in 31, fatigue in 21, dry mouth in 1, and other in 2. Missing CPET data resulted when one patient removed the pulse oximeter at maximal exercise, and one patient dismounted the cycle ergometer before recovery measurements could be taken. As only 55% of the cohort achieved AT, we limited our subsequent analyses to unloaded, peak, and 1-min recovery measurements.
Predictors of patient survival
Survival at one year from evaluation with CPET was 72% (95% CI, 54-84%) for the entire cohort (including post-transplant survival). Seven patients underwent lung transplantation during the study period. There were 17 deaths in our cohort with 1 death post-transplant. Median follow-up was 271 (23-983) days. Black race or Hispanic ethnicity, lower DLCO % predicted, pulmonary hypertension, and a 6MWTD o350 m (median) conferred an increased risk of death even after ' ' controlling'' for lung transplantation (Table 3) . Oxygen saturation throughout CPET was inversely proportional to the risk of death, as were peak VO 2 /kg and peak oxygen pulse (VO 2 /HR). The results were unchanged after adjusting for the use of supplemental oxygen during the test. Patients who used supplemental oxygen during CPET had a lower DLCO % predicted and a higher mean pulmonary artery pressure than those tested on room air (Po0:05).
There was a significant increase in risk for those patients with peak or recovery ventilatory equivalent for carbon dioxide (V E /VCO 2 )446 (the upper quartile) (Po0:05). The risk associated with an increased V E /VCO 2 was non-proportional and increased over time; therefore, this result could not be estimated with a single HR or P value. Subset analyses limited to patients with UIP showed similar results. For example, patients with UIP who walked o350 m in 6 min had more than 8 times the risk of death of those with UIP who walked X350 m in 6 min.
ARTICLE IN PRESS
Derivation of optimal clinical predictors for ' ' Death on the List''
In the second analysis, we assessed variables which distinguished patients who died on the list from those who were alive or received a lung transplant. We included listed patients with complete data (N ¼ 25) (Table 4 ). An AUC of 1.0 indicates an ideal test, which can perfectly discriminate between a patient who will die on the list while awaiting lungs, and a patient who will remain alive. An AUC of 0.50 is no better than chance; such a test has no ability to discriminate between patients who live and those who die. A 95% CI which excludes 0.50 indicates a prognostic parameter which performs better than chance. We found that oxygen saturation with unloaded exercise and 6MWTD were the best predictors. A cutoff of oxygen saturation of o95% during unloaded exercise had a sensitivity of 86% (95% CI, 42-100%) and a specificity of 89% (95% CI, 65-99%) to predict death on the list. For a patient with oxygen saturation of o95%, there was a 75% chance of dying on the list. A patient with oxygen saturation during unloaded exercise X95% would have a 94% chance of being alive or receiving a lung transplant. Similarly, a patient with a 6MWTD o350 m would have a 67% chance of dying on the list. A patient with a 6MWTD X350 m would have a 94% chance of being alive or receiving a lung transplant. These results did not change after adjusting for supplemental oxygen use during CPET.
There were significant differences in survival for patients with low oxygen saturation during unloaded exercise or low 6MWTD using these cutoffs in our entire cohort (Figs. 1a and b ). There were similar findings in the subset of patients with UIP (Figs. 2a and b) . Patients who underwent transplantation were censored as alive in this analysis.
Model checking revealed reasonable fit of all of the regression models. Although we identified a few influential subjects for each regression coefficient, deletion of these subjects from the data set and reanalysis generally produced more dramatic, but consistent, effect estimates for each statistically significant predictor. In no case did these analyses substantially change the effect estimates from the full data set.
Discussion
Functional assessment of patients with DPLD who are evaluated for lung transplantation offers the promise of improved risk stratification beyond that provided by conventional measures of lung disease. The recent ATS/ACCP Statement on Cardiopulmonary Exercise Testing highlighted the potential of CPET for determining prognosis in pulmonary fibrosis, however, deemed this use of CPET to be ' ' controversial''. 11 The ATS has recommended 6 min walk testing for the prediction of mortality in chronic obstructive pulmonary disease and primary pulmonary hypertension, however, this committee did not recommend the walk test for the prediction of mortality in DPLD, likely due to insufficient evidence. 10 Our data show that VO 2 /kg, oxygen saturation, V E /VCO 2 , and 6MWTD are associated with the risk of death in patients with DPLD who were evaluated for lung transplantation. We found that lower oxygen saturation during exercise or recovery was associated with an increased risk of death, similar to the findings of others. 5 Oxygen desaturation with exercise is common in patients with DPLD. 20, 21 The potential mechanisms of oxygen desaturation include V/Q mismatching, diffusion limitation, intrapulmonary shunt, low mixed venous oxygen saturation, and a patent foramen ovale with right-to-left shunting of deoxygenated blood. Considering these determinants of systemic oxygen desaturation during exercise, it is not surprising that this measure was so strongly and consistently associated with outcomes.
Patients who used supplemental oxygen during testing had results similar to those of patients who did not use supplemental oxygen. While this may be unexpected, it appears that individuals who used oxygen as outpatients (and therefore oxygen during the testing) were more severely affected than those who did not. It follows that the same cutoff value of oxygen saturation predicts an increased risk of death both in sicker patients using supplemental oxygen and in healthier patients who did not use oxygen therapy during the testing. Another important finding of our study was the association of a reduced VO 2 /kg with an increased risk of death. Systemic oxygen saturation, hemoglobin level, oxyhemoglobin dissociation kinetics, cardiac output, and tissue extraction factors affect oxygen consumption. Collectively, these extrapulmonary aspects of chronic lung disease may influence functional status and prognosis before and after lung transplantation. [22] [23] [24] Indeed, while lung transplantation ' ' treats'' the pulmonary component of DPLD, systemic impairments in exercise performance persist. 25, 26 The primary inflammatory disease process (or medications used to treat it) may affect myocardial, diaphragmatic, vascular, and peripheral muscular function, altering the post-transplant course.
Inefficient ventilation (or increased V E /VCO 2 ) at peak exercise was associated with an increased risk of death. Although this measure may reflect the severity of parenchymal lung disease, there are other interpretations. 27 For example, patients with primary pulmonary hypertension commonly have an increased V E /VCO 2 and an increased V E /VCO 2 slope. 28, 29 These findings are thought to result from V/Q mismatch, shunting of acidemic blood through a patent foramen ovale, increased afferent stimuli from the lungs or heart, and/or hypoxemia, resulting in increased respiratory drive. Pulmonary vascular disease in DPLD may increase both V E / VCO 2 and the risk of death, independent of the parenchymal disease. 22, [30] [31] [32] This is supported by the association of the risk of death with DLCO% predicted and pulmonary artery pressures in our cohort, but not with lung volumes or spirometry.
It would be useful to develop criteria to distinguish patients with DPLD with a high risk of death while awaiting lung transplantation. Other studies of this issue differ from ours in several ways. [4] [5] [6] 8, 9, 13, 14, 22 These cohorts included racially and ethnically homogenous patient groups, whereas almost 30% of our patients were black or Hispanic, mirroring the demographics of the United States.
Patients in our cohort had worse lung function than that of patients in other studies. 13, 14 For example, Lama et al. excluded patients with resting hypoxemia on room air (only 15% of the total cohort), while approximately 60% of the patients in our cohort required oxygen at rest (and therefore with exercise testing). 13 These differences in severity of illness and the use of supplemental oxygen during walk testing likely explain why oxygen desaturation predicted outcome in other studies, whereas the 6MWTD predicted outcome in ours. 13, 14 Lastly, some studies excluded outlying (or ' ' influential'') subjects, whereas we included all eligible patients, a conservative strategy reflecting the clinical ' ' real-life'' heterogeneity of this population. A recent informative study of patients with UIP excluded patients who eventually underwent lung transplantation-an approach which limits its applicability to our population of interest. 3 While others have shown the predictive value of 6 min walk testing in patients awaiting lung transplantation, the optimal prognostic parameter is not welldefined in patients with DPLD. In our study, we found excellent sensitivity and specificity of oxygen saturation o95% with unloaded exercise and 6MWTD o350 m for prediction of death on the list for patients with DPLD. For a patient with oxygen saturation of o95%, there was a 75% chance of dying on the list. In a priority-based lung allocation system, such a patient could be given higher priority for lung transplantation, given the otherwise dismal prognosis. Another patient with oxygen saturation during unloaded exercise X95% would have a 94% chance of being alive or receiving a lung transplant-this patient could be reassured that there was less urgency for immediate transplantation and could be monitored over time. Similarly, a patient with a 6MWTD o350 m would have a 67% chance of dying on the list; such a patient could be granted a ' ' high urgency'' status for transplantation. A patient with a 6MWTD X350 m would have a 94% chance of being alive or receiving a lung transplant. This patient could be given lower priority for lung transplantation and managed expectantly. Although our findings rival other published predictors of death in patients awaiting transplantation, they need to be validated before making firm recommendations.
We found an unexpected increased risk of death for patients who were black or Hispanic, which persisted despite adjustment for listing, transplantation, DLCO % predicted, 6MWTD, or pulmonary artery pressure (data not shown). The possible presence of confounding by physiologic differences or lead-time bias does not mitigate the fact that patients who are black or Hispanic have a higher risk of death after referral, regardless of listing and transplantation status. If confirmed, these findings should spur outreach and education regarding lung transplantation for physicians with a high proportion of black or Hispanic patients and the patients themselves.
There are several limitations to our study. Our source population, patterns of referral, transplant waiting times, and cohort characteristics may differ from those of other lung transplant programs. Confounding may be present, as a small number of endpoints limited our ability to perform extensive multivariate analyses. However, as most of the physiologic variables in our analysis are in the causal pathway, adjusting for these factors would not necessarily be appropriate. Misclassification of outcomes is unlikely, as we had a 0% loss to follow-up rate. Although testing with supplemental oxygen could alter the test performance, we did not find significant changes in our results after adjusting for oxygen use during testing. Many of these patients were prescribed supplemental oxygen for daily activities; performing maximal exercise testing without prescribed therapy is neither reasonable nor clinically useful.
Conclusion
In summary, we have characterized CPET findings in a cohort of patients with advanced DPLD referred for lung transplantation. We have identified associations between pulmonary hypertension, 6MWTD, oxygen saturation during exercise, peak VO 2 /kg, VO 2 /HR, and V E /VCO 2 with outcomes. We have also found oxygen saturation o95% during unloaded exercise and 6MWTD o350 m to be sensitive and specific predictors of death on the transplant waiting list. These results may elucidate the causes of morbidity and mortality in DPLD. Furthermore, considering the strong prognostic relationship with survival, these measures may potentially serve as surrogate endpoints for clinical trials of therapy for DPLD. Lastly, validation of these CPET findings and eventual incorporation into priority-based allocation algorithms for lung transplantation could improve patient outcomes on the waiting list.
